Bayer appoints Dr. Juergen Eckhardt as new Head of Pharmaceuticals Business Development & Licensing/Open Innovation
Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer
Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer
Acquisition of exclusive commercialization rights for European markets
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
Subscribe To Our Newsletter & Stay Updated